115480 — CU Medical Systems Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapValue Trap

Annual income statement for CU Medical Systems, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	28,319	35,402	46,957	41,803	40,629
Cost of Revenue
Gross Profit	12,487	18,476	24,701	20,403	21,545
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	38,362	37,116	36,462	39,518	33,480
Operating Profit	-10,043	-1,714	10,496	2,285	7,149
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-18,290	-15,140	10,446	-7,443	-2,474
Provision for Income Taxes
Net Income After Taxes	-20,749	-14,141	9,511	-8,136	-3,141
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-25,741	-13,981	9,425	-8,204	-3,204
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-25,741	-13,981	9,425	-8,204	-3,204
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-639	-240	204	-136	-53.8
Dividends per Share